Cerebrospinal fluid HIV-1 compartmentalization in a patient with AIDS and acute Varicella-Zoster virus meningomyeloradiculitis

Clinical Infectious Diseases

Volumn 57, Issue 5, 2013, Pages

  Falcone, E Liana ^a   Adegbulugbe, Ademiposi A ^b   Sheikh, Virginia ^a   Imamichi, Hiromi ^a   Dewar, Robin L ^c   Hammoud, Dima A ^d   Sereti, Irini ^a   Lane, H Clifford ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b WASHINGTON HOSPITAL CENTER   (United States)

^c SAIC FREDERICK INC   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

central nervous system compartmentalization; human immunodeficiency virus; meningomyeloradiculitis; varicella zoster virus; viral quasispecies

Indexed keywords

ACICLOVIR; COCAINE; EFAVIRENZ PLUS EMTRICITABINE PLUS TENOFOVIR DISOPROXIL; FAMCICLOVIR; METHYLPREDNISOLONE; VALACICLOVIR; ANTIVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AFRICAN AMERICAN; AIDS PATIENT; ANTIVIRAL THERAPY; ARTICLE; CASE REPORT; CD4 LYMPHOCYTE COUNT; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID CULTURE; CONCURRENT SEXUAL PARTNERSHIP; DISEASE ASSOCIATION; DISEASE DURATION; DRUG USE; EPSTEIN BARR VIRUS; FALLING; FOLLOW UP; HOSPITAL ADMISSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOPROPHYLAXIS; LIMB WEAKNESS; MALE; MENINGOMYELOCELE; MENINGOMYELORADICULITIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; PLEOCYTOSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RADICULITIS; REAGIN TEST; SMOKING; THORAX PAIN; THRUSH; TREATMENT DURATION; UNPROTECTED SEX; VARICELLA ZOSTER VIRUS; VESICULAR RASH; VIRUS LOAD; ACQUIRED IMMUNODEFICIENCY SYNDROME; COMPLICATION; HERPES ZOSTER; ISOLATION AND PURIFICATION; MIDDLE AGED; MYELITIS; PATHOLOGY; RADICULOPATHY; VIROLOGY; VIRUS MENINGITIS;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANTIVIRAL AGENTS; CEREBROSPINAL FLUID; HERPES ZOSTER; HIV-1; HUMANS; MALE; MENINGITIS, VIRAL; MIDDLE AGED; MYELITIS; RADICULOPATHY;

EID: 84881472613     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cit356     Document Type: Article

References (28)

1. Lauring AS, Andino R. Quasispecies theory and the behavior of RNA viruses. PLoS Pathog 2010; 6:e1001005.
2. Blackard JT. HIV compartmentalization: A review on a clinically important phenomenon. Curr HIV Res 2012; 10:133-42.
3. van't Wout AB, Ran LJ, Kuiken CL, Kootstra NA, Pals ST, Schuitemaker H. Analysis of the temporal relationship between human immunodeficiency virus type 1 quasispecies in sequential blood samples and various organs obtained at autopsy. J Virol 1998; 72:488-96.
4. Nickle DC, Shriner D, Mittler JE, Frenkel LM, Mullins JI. Importance and detection of virus reservoirs and compartments of HIV infection. Curr Opin Microbiol 2003; 6:410-6.
5. Smit TK, Brew BJ, Tourtellotte W, Morgello S, Gelman BB, Saksena NK. Independent evolution of human immunodeficiency virus (HIV) drug resistance mutations in diverse areas of the brain in HIV-infected patients, with and without dementia, on antiretroviral treatment. J Virol 2004; 78:10133-48.
6. Ritola K, Robertson K, Fiscus SA, Hall C, Swanstrom R. Increased human immunodeficiency virus type 1 (HIV-1) env compartmentalization in the presence of HIV-1-associated dementia. J Virol 2005; 79:10830-4.
7. De La Blanchardiere A, Rozenberg F, Caumes E, et al. Neurological complications of varicella-zoster virus infection in adults with human immunodeficiency virus infection. Scand J Infect Dis 2000; 32:263-9.
8. Gnann JW Jr. Varicella-zoster virus: Atypical presentations and unusual complications. J Infect Dis 2002; 186(suppl 1):S91-8.
9. Newsome SD, Nath A. Varicella-zoster virus vasculopathy and central nervous system immune reconstitution inflammatory syndrome with human immunodeficiency virus infection treated with steroids. J Neurovirol 2009; 15:288-91.
10. Imamichi H, Degray G, Dewar RL, et al. Lack of compartmentalization of HIV-1 quasispecies between the gut and peripheral blood compartments. J Infect Dis 2011; 204:309-14.
11. Jensen MA, Coetzer M, van't Wout AB, Morris L, Mullins JI. A reliable phenotype predictor for human immunodeficiency virus type 1 subtype C based on envelope V3 sequences. J Virol 2006; 80:4698-704.
12. Vafai A, Berger M. Zoster in patients infected with HIV: A review. Am J Med Sci 2001; 321:372-80.
13. Ohagen A, Devitt A, Kunstman KJ, et al. Genetic and functional analysis of full-length human immunodeficiency virus type 1 env genes derived from brain and blood of patients with AIDS. J Virol 2003; 77:12336-45.
14. Meylan PRA, Miklossy J, Iten A, et al. Myelitis due to varicella-zoster virus in an immunocompromised patient without a cutaneous rash. Clin Infect Dis 1995; 20:206-8.
15. Manian FA, Kindred M, Fulling KH. Chronic varicella-zoster virus myelitis without cutaneous eruption in a patient with AIDS: Report of a fatal case. Clin Infect Dis 1995; 21:986-8.
16. Bagasra O, Lavi E, Bobroski L, et al. Cellular reservoirs of HIV-1 in the central nervous system of infected individuals: Identification by the combination of in situ polymerase chain reaction and immunohistochemistry. AIDS 1996; 10:573-85.
17. Gonzalez-Scarano F, Martin-Garcia J. The neuropathogenesis of AIDS. Nat Rev Immunol 2005; 5:69-81.
18. Peluso MJ, Ferretti F, Peterson J, et al. Cerebrospinal fluid HIV escape associated with progressive neurologic dysfunction in patients on antiretroviral therapy with well-controlled plasma viral load. AIDS 2012; 26:1765-74.
19. Canestri A, Lescure FX, Jaureguiberry S, et al. Discordance between cerebral spinal fluid and plasma HIV replication in patients with neurological symptoms who are receiving suppressive antiretroviral therapy. Clin Infect Dis 2010; 50:773-8.
20. Strain MC, Letendre S, Pillai SK, et al. Genetic composition of human immunodeficiency virus type 1 in cerebrospinal fluid and blood without treatment and during failing antiretroviral therapy. J Virol 2005; 79:1772-88.
21. Korber BT, Kunstman KJ, Patterson BK, et al. Genetic differences between blood- and brain-derived viral sequences from human immunodeficiency virus type 1-infected patients: Evidence of conserved elements in the V3 region of the envelope protein of brain-derived sequences. J Virol 1994; 68:7467-81.
22. Pang S, Vinters HV, Akashi T, O'Brien WA, Chen IS. HIV-1 env sequence variation in brain tissue of patients with AIDS-related neurologic disease. Acquir Immune Defic Syndr 1991; 4:1082-92.
23. Chang CC, McLean C, Vujovic O, et al. Fatal acute varicella-zoster virus hemorrhagic meningomyelitis with necrotizing vasculitis in an HIV-infected patient. Clin Infect Dis 2009; 48:372-3.
24. de Silva SM, Mark AS, Gilden DH, et al. Zoster myelitis: Improvement with antiviral therapy in two cases. Neurology 1996; 47:929-31.
25. Lionnet F, Pulik M, Genet P, et al. Myelitis due to varicella-zoster virus in two patients with AIDS: Successful treatment with acyclovir. Clin Infect Dis 1996; 22:138-40.
26. Gomez-Tortosa E, Gadea I, Gegundez MI, et al. Development of myelopathy before herpes zoster rash in a patient with AIDS. Clin Infect Dis 1994; 18:810-2.
27. Gray F, Belec L, Lescs MC, et al. Varicella-zoster virus infection of the central nervous system in the acquired immune deficiency syndrome. Brain 1994; 117(Pt 5):987-99.
28. Devinsky O, Cho ES, Petito CK, Price RW. Herpes zoster myelitis. Brain 1991; 114(Pt 3):1181-96.